Recruiting

Application of Radiomics in Breast Cancer

Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.

ClinicalTrials.gov IDNCT04483804

PhaseNot Applicable

Enrollment2000

SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Breast Cancer, Ultrasound, Elastography, Pathology, Radiomics

About this study

Interventions

Combination Product: Endocrine therapy — Endocrine therapy

Primary outcomes

metastasis (through study completion, an average of 1 year)
death (through study completion, an average of 1 year)

Eligibility information

Inclusion Criteria: Clinical diagnosis of breast cancer Exclusion Criteria: Missing pathology Missing follow-up results Missing data

Study locations

the Second Affiliated Hospital Zhejiang University School of Medicine, Hanzhou, Zhejiang 310009 China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.